248 related articles for article (PubMed ID: 15299030)
21. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
22. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
23. Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex.
McMahon LW; Walsh CE; Lambert MW
J Biol Chem; 1999 Nov; 274(46):32904-8. PubMed ID: 10551855
[TBL] [Abstract][Full Text] [Related]
24. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
25. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.
Kuang Y; Garcia-Higuera I; Moran A; Mondoux M; Digweed M; D'Andrea AD
Blood; 2000 Sep; 96(5):1625-32. PubMed ID: 10961856
[TBL] [Abstract][Full Text] [Related]
26. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.
Garcia-Higuera I; Kuang Y; Denham J; D'Andrea AD
Blood; 2000 Nov; 96(9):3224-30. PubMed ID: 11050007
[TBL] [Abstract][Full Text] [Related]
27. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice.
Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC
J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134
[TBL] [Abstract][Full Text] [Related]
28. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
[TBL] [Abstract][Full Text] [Related]
29. Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR.
Pang Q; Christianson TA; Koretsky T; Carlson H; David L; Keeble W; Faulkner GR; Speckhart A; Bagby GC
J Biol Chem; 2003 Oct; 278(43):41709-17. PubMed ID: 12882984
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
31. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.
Freie B; Li X; Ciccone SL; Nawa K; Cooper S; Vogelweid C; Schantz L; Haneline LS; Orazi A; Broxmeyer HE; Lee SH; Clapp DW
Blood; 2003 Dec; 102(12):4146-52. PubMed ID: 12855557
[TBL] [Abstract][Full Text] [Related]
32. The Fanconi anemia core complex associates with chromatin during S phase.
Mi J; Kupfer GM
Blood; 2005 Jan; 105(2):759-66. PubMed ID: 15256425
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.
Rathbun RK; Faulkner GR; Ostroski MH; Christianson TA; Hughes G; Jones G; Cahn R; Maziarz R; Royle G; Keeble W; Heinrich MC; Grompe M; Tower PA; Bagby GC
Blood; 1997 Aug; 90(3):974-85. PubMed ID: 9242526
[TBL] [Abstract][Full Text] [Related]
34. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells.
Zhang X; Li J; Sejas DP; Pang Q
Blood; 2005 Jul; 106(1):75-85. PubMed ID: 15769896
[TBL] [Abstract][Full Text] [Related]
36. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
37. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
38. Posttranscriptional cell cycle-dependent regulation of human FANCC expression.
Heinrich MC; Silvey KV; Stone S; Zigler AJ; Griffith DJ; Montalto M; Chai L; Zhi Y; Hoatlin ME
Blood; 2000 Jun; 95(12):3970-7. PubMed ID: 10845936
[TBL] [Abstract][Full Text] [Related]
39. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic correction of Fanconi anemia group C knockout mice.
Gush KA; Fu KL; Grompe M; Walsh CE
Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]